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OPIOID ANALGESIA IN CHILDREN
Opioid infusions are essential therapy for children
in severe pain. Patient controlled analgesia (PCA) is
an attractive treatment option because of the mul-
tiple beneﬁts it provides: immediate and effective
pain relief, titration of analgesia and empowerment
of the patient (or nurse) to have a degree of
control over their pain which helps to retain auton-
omy and decrease anxiety. However, opioid infu-
sions for children carry a high risk of medication
error. Risks include the complexity in calculating
dosages, the manipulation of small volumes to
prepare individual infusions and the necessity to
deliver the infusion with precision at low ﬂow rates
(down to 0.1 mL/h). During PCA additional
boluses on top of the baseline infusion rate add to
the pharmaceutical and therapeutic complexity.
The severe side effects of opioids, including hypo-
ventilation, hypotension and sedation, exacerbate
the risk and raise great concern in hospitals, plus
limiting the use of PCA in community and hospice
settings.
At present there is no international standard
practice or guideline on the way that PCA is admi-
nistered. This commentary highlights problems
with current practices of preparing and administer-
ing PCA in hospitalised children in the UK.
Additionally, we advocate a system management
approach which we are piloting to address the pro-
blems of opioid-based PCA for children in a large
(200-bed) hospital, the Evelina London Children’s
Hospital, in the hope of developing safer practices
for the delivery of opioid analgesia.
OPIOID INFUSIONS IN PAEDIATRIC PHARMACY
Intravenous infusions are an important means of
administering therapy, yet the technical process is
complex with multiple error-prone steps. The
errors associated with preparing and administering
intravenous infusions in paediatrics (eg, low
volume at low ﬂow rate) make drug delivery by
infusion a particularly high risk,1 but continuous
infusions of opioid are crucial to achieve effective
analgesia and avoid uncontrolled pain in neonates
and children with conditions such as sickle cell
disease and post surgery. Administering infusions to
children requires complex dose calculations, infu-
sion rate adjustments and often requires several
manipulations of injectable medicines to obtain the
ﬁnal ‘ready to use’ infusion solution. Errors involv-
ing the wrong diluent or volume/dose or wrong
infusion rate are common, with incidence rates
between 1.6% and 91.7% reported.2–6 Tenfold or
greater dose errors have been reported through
misplacement of the decimal point. For example a
premature baby died 28 h after birth when a junior
doctor prescribed 15 mg of intravenous morphine
instead of 0.15 mg, resulting in administration of a
100 times overdose.7 We consider that the risk of
error for potent medicines such as morphine under
current practices is not acceptable.
The preparation of individually manufactured
syringes presents a signiﬁcant source of error in
opioid infusions. This problem was quantiﬁed in a
study by Parshuram et al8 in which discrepancies
were measured between prescribed and delivered
concentrations of opioid infusions in neonatal and
paediatric intensive care units. The study found
that 6% of morphine infusions (prepared at ward
level) had a twofold or greater concentration error.
A second study identiﬁed a high rate of errors
during drug-volume calculations or introduced by
rounding off of volume and dose, that is, rounding
the calculation to the nearest measurable volume
(eg, 2.46–2.5 mL) to match syringe graduations,
during the preparation of morphine syringes.4 Of
the 464 morphine infusions prepared during the
course of the study, 34.7% had a concentration
error (deviation of 10% or greater from expected
concentration).
While error introduced by rounding may appear
minimal initially, it can be compounded by inaccur-
acies during the multiple-step infusion preparation
process. A typical example (box 1) highlights the
variability arising from the manufacturing method
and the scope for calculation error. However, it has
to be acknowledged that practices vary and there-
fore the source and magnitude of variance or error
may differ.
Standardisation of morphine concentrations for
infusions and batch manufacture to pharmacopoeial
standards of accuracy removes individualised prep-
aration as a source of error. It has been reported
that 21% of errors associated with paediatric infu-
sions can be avoided if the reconstitution and dilu-
tion steps are replaced by the use of preprepared
syringes.9 However, it has to be acknowledged that
it is essential to agree to one set of standard solu-
tions in order to move towards batch manufacture
and consistent working across the profession.
Unlike adult practice where all patients receive a
single standard adult dose, children’s doses are calcu-
lated on the basis of their weight, which may range
from 0.5 kg to 100 kg (a difference of 200 times).
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This means that more complex calculations are required to
produce paediatric preparations. Current practice in UK and
European hospitals is to prepare syringes individually for children
using a system called the ‘rule of 6’ (box 2) to calculate the infu-
sion rate for paediatric drug infusions which are prescribed in
micrograms (μg) per kilogram per minute.9
LOCAL EXPERIENCE OF ERROR WITH MORPHINE
INFUSIONS
Studies by Rashed et al conducted on paediatric wards in hospi-
tals in European and non-European countries including;
Australia, Germany, UK, Malaysia, China (Hong Kong) and
Saudi Arabia; in 2008–2009 and 2010 identiﬁed morphine as:
(A) the drug associated with the highest number of medication
errors, (B) more frequently prescribed for paediatric patients in
UK compared with other countries.10–12 Similar ﬁndings have
been reported by others.13
A project was conducted in the paediatric intensive care unit
at Evelina London Children’s Hospital in the UK to convert
morphine infusions from the named patient model (using the
rule of 6), to dose-banded standard concentrations of morphine
prepared by pharmacy. The standard concentrations were pre-
pared in 50 mL volumes as quality assured preﬁlled syringes at
the pharmacy manufacturing unit at Guy’s and St Thomas NHS
Foundation Trust using batch manufacture with quality control
to verify that the concentrations are within the British
Pharmacopoeia14 limits for morphine sulfate injection, that is,
±7.5% of the label strength. Safety pumps with accurate display
of low ﬂow rates and programmable software features including
lockout intervals, limits on the total dosage in a set time interval
and patient administered dosing were used to deliver the
infusions. A review of the hospital incident reporting system
2 years post implementation showed that errors of wrong
diluent and wrong dose prepared were entirely eliminated
(unpublished data). However, there was no signiﬁcant change in
the reported error frequency over 2 years preimplementation
and postimplementation. While the low reporting makes this
data clinically insigniﬁcant, it is unquestionable that the standar-
dised syringes are far more accurate (quality assured certiﬁed)
compared with the ward-made syringes, suggesting a much
improved system. In another study at the same hospital the
accuracy of morphine infusions prepared for neonates in the
neonatal intensive care unit was measured. It was found that
19.2% of morphine infusions prepared by nurses in the neo-
natal intensive care unit were outside the British
Pharmacopoeia14 concentration limits for morphine sulfate
injection, with more than 20% deviation in concentrations iden-
tiﬁed. The study also found that the smaller the volume of mor-
phine injection required to prepare the infusions, the greater the
magnitude and frequency of deviation from the intended
concentration.15
STANDARDISATION AS A SYSTEM MANAGEMENT
APPROACH TO SAFER PCA
The studies described above establish the nature and source of
some of the errors associated with morphine therapy. This laid
the ground work for our current initiative to develop a system
management approach to eliminate the risk of medication error
in the most challenging setting: patient-controlled analgesia for
children using morphine. Our proposed solution is a system to
minimise complex calculations and individualised medicine
manufacture at the point of administration by providing stand-
ard dose-banded concentrations of morphine infusion for PCA
administration using preprogrammed safety pumps for hospita-
lised paediatric patients. Implementing the new system of mor-
phine standard concentrations is taking place in three phases.16
The implementation of a standardised dose-banded infusion
system for morphine delivery by patient-controlled analgesia for
children has not to our knowledge, been implemented anywhere
in the world to date. Preprepared syringes containing standard
concentrations of intravenous infusions have been introduced
sporadically in the UK and internationally over the last few
years.15 17–19 A study in children determined that the number of
reported errors associated with continuous medication infusions
dropped by 73% after implementation of standard drug concen-
trations solutions administered using advanced safety pumps
with inbuilt drug libraries and default settings to facilitate selec-
tion of correct medication and dose.18 Standardising infusion
concentrations is recognised internationally as an important step
in improving patient safety.20 A UK Department of Health
commissioned study concluded that the introduction of standar-
dised dose-banded syringes, manufactured by centralised intra-
venous additive services, used with a preprogrammed safety
pump would avoid the most common dosing errors in neonates
and paediatrics.17 However, challenges such as establishing dose
bands, availability of sufﬁciently accurate, programmable
pumps, capacity to manufacture or quality assure the injections,
and availability of secure and sufﬁcient storage have prevented
the implementation of these recommendations to date.
To avoid error in the preparation and delivery of morphine to
children by infusion we are piloting standardised quality assured
preﬁlled syringes of dose-banded infusions (at three concentra-
tions) for administration via preprogrammed safety pumps
(ﬁgure 1).21 The lockable pumps are capable of delivering indi-
vidualised PCA for hospitalised paediatric patients in intensive
Box 2 The Rule of Six
The formula is described as: 6×patient’s weight (kg) equals the
amount of drug in milligrams that should be added to 100 mL
of solution. When administered at 1 mL/h will give an infusion
rate of 1 μg/kg/min (or 60 μg/kg/h).9
Box 1 An example of inaccuracies arising in the
preparation of a paediatric morphine infusion
If a 24 week baby of 470 g requires morphine at a dose of 10 μg/
kg/h this can be achieved by preparing ‘(5×weight (g))/1000 mg
in 50 mL’ then administering at 0.1 mL/h to provide the target
dose of 10 μg/kg/h. To manufacture the infusion, the dose of
morphine is (5×470)/1000=2.35 mg, which is to be diluted up to
50 mL. Morphine sulfate is available as a 10 mg/mL injection,
thus the 2.35 mg dose is in 0.235 mL volume. As the syringes are
only accurate to 0.1 mL, a volume of 0.2 mL (2 mg) will be
placed in 50 ml (should be 49.8 mL, but a 50-mL syringe is not
accurate enough). So, the prepared product, 2 mg in 50.2 mL,
has a concentration of 0.0398 mg/mL which when administered
at 0.1 mL/h provides a dose of 3.98 μg/h. This is a signiﬁcant
deviation from the prescribed dose of 4.7 μg/h (10 μg/kg/h).
In this example there is 15% variance based on the
calculation, plus the potential for 10-fold errors and the
likelihood of inaccuracy of measurement during preparation.
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and non-intensive areas with accuracy and precision.
Preprogramming of the pump with the standard strength
removes the possibility of miscalculating the administration rate,
which will be set according to the patient’s weight. Use of the
wrong strength infusion for the programme is a potential error
and could be eliminated using bar coding, which is an option
that is being explored. Standardised infusions were banded
based on child’s weight (<4–≥20 kg) after considering the rate
of delivery that would be necessary for infusions with morphine
concentrations of 1–50 mg in 50 mL. The three identiﬁed stand-
ard morphine concentrations will be implemented slowly across
different units within the hospital to allow for evaluation and
review of the established bands in practice, before full roll-out
across the hospital. These standard infusions will be adminis-
tered as per the current N/PCA protocols used at the Trust; for
example nurse-controlled analgesia (NCA) protocol runs at an
infusion rate of 20 μg/kg/h with bolus dose of 10 μg/kg.
Even at the extremes of the weight range, the dose-banded
system will deliver the prescribed dose. With the ‘rule of 6’
method however, although inaccurate infusion preparation may
be compensated for by titrating the N/PCA according to
response, it is still an unacceptable method of practice and will
inﬂuence the clinical judgement about a child’s pain when syr-
inges are changed. For example, a syringe that has a concentra-
tion that is 20% too high changed to a syringe that has a
concentration 30% too low would lead to an observation that a
child’s pain is signiﬁcantly increasing.
We hope that the implementation of the standard morphine
concentrations for PCA use in children will result in demon-
strable risk reduction compared with current practice.
Furthermore, the system is anticipated to provide welcome eco-
nomic savings, simplicity of use and efﬁciencies in staff time.
Ultimately the aim is to make this vital but currently high risk
therapy less risky and thus more widely available, that is,
extending the use to environments such as ambulatory care and
community settings where cost, complexity and risk currently
restrict the access of children to PCA.
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